Safety Study for a Gamma Delta T Cell Product Used With Low Dose Radiotherapy in Patients With Stage 4 Metastatic NSCLC

Conditions: Carcinoma, Non-Small-Cell Lung Interventions: Biological: KB-GDT-01 Sponsors: Kiromic BioPharma Inc.; Stiris Research Inc; Statistics& Data Corporation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials